429 related articles for article (PubMed ID: 29948756)
21. Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.
Kittelson JM; Steg PG; Halperin JL; Goldenberg NA; Schulman S; Spyropoulos AC; Kessler CM; Turpie AG; Cutler NR; Hiatt WR;
Thromb Haemost; 2016 Aug; 116(3):544-53. PubMed ID: 27346176
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
23. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
Chevalier J; Giroud M; de Pouvourville G
Cerebrovasc Dis; 2013; 35(4):320-6. PubMed ID: 23615428
[TBL] [Abstract][Full Text] [Related]
24. Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses.
Spencer RJ; Amerena JV
Am J Cardiovasc Drugs; 2015 Dec; 15(6):395-401. PubMed ID: 26062914
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients?
Balsam P; Tymińska A; Ozierański K; Zaleska M; Żukowska K; Szepietowska K; Maciejewski K; Peller M; Grabowski M; Lodziński P; Kołtowski Ł; Praska-Ogińska A; Zaboyska I; Bednarski J; Filipiak KJ; Opolski G
Cardiol J; 2020; 27(5):590-599. PubMed ID: 30406937
[TBL] [Abstract][Full Text] [Related]
26. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Link MS; Giugliano RP; Ruff CT; Scirica BM; Huikuri H; Oto A; Crompton AE; Murphy SA; Lanz H; Mercuri MF; Antman EM; Braunwald E;
Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28077507
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
28. Stroke prevention in atrial fibrillation: do we still need warfarin?
Diener HC; Weber R; Lip GY; Hohnloser SH
Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
Casciano JP; Singer DE; Kwong WJ; Fox ES; Martin BC
Am J Cardiovasc Drugs; 2012 Oct; 12(5):313-23. PubMed ID: 22920047
[TBL] [Abstract][Full Text] [Related]
30. Simulation of anticoagulation in atrial fibrillation patients with rivaroxaban-from trial to target population.
Zhang C; Wang WW; Pan MM; Gu ZC
Rev Cardiovasc Med; 2021 Sep; 22(3):1019-1027. PubMed ID: 34565103
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
32. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR;
Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682
[TBL] [Abstract][Full Text] [Related]
33. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
34. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Agarwal S; Hachamovitch R; Menon V
Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
[TBL] [Abstract][Full Text] [Related]
35. Target-specific oral anticoagulants in patients undergoing cardioversion.
Law EH; Gordon W
Am J Health Syst Pharm; 2014 Jul; 71(14):1171-6. PubMed ID: 24973374
[TBL] [Abstract][Full Text] [Related]
36. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
Wipf JE
West J Med; 1995 Aug; 163(2):145-52. PubMed ID: 7571562
[TBL] [Abstract][Full Text] [Related]
38. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
39. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
40. Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.
Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
